Chiara Sacco

Istituto Superiore di Sanità

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (5)

claudia fortuna

Istituto Superiore di Sanità

ITALY

View details

Daniele Petrone

Istituto Superiore di Sanità

ITALY

View details

Marco Ajelli

Associate Professor

Indiana University Bloomington School of Public Health

UNITED STATES

View details

Angela Di Martino

Istituto Superiore di Sanità

ITALY

View details

Hinta Meijerink

Norwegian Institute of Public Health

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chiara Sacco

Research Interests

Explore related searches

Contact this professor

Articles (10)

COVID-19 vaccine effectiveness in the paediatric population aged 5–17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022

Autochthonous dengue outbreak in Marche Region, Central Italy, August to October 2024

The impact of underreported infections on vaccine effectiveness estimates derived from retrospective cohort studies

Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality

Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19

Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023

Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)

Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study

Network analysis of early school dropouts’ risk factors in Italy

Collaborators (5)

claudia fortuna

Daniele Petrone

Marco Ajelli

Angela Di Martino

Hinta Meijerink

Make your next move.